Business

Facts and myths about medical cannabis in Poland

Pain management societies around the world recognize and recommend cannabis for its proven efficacy in the treatment of chronic pain. In Poland, the act of legalizing cannabis for medical purposes came into effect on November 2017. Patients can buy medical cannabis in pharmacies, though it is available only on prescription. As of January 2019, Poland became an importer of the plant.

Poland’s citizens need education about medical cannabis, as their safety during treatments depends on it. Information on the effects and ingredients of cannabis are important. “This is important for the patients, but it’s also important for the medical staff,” says Tomasz Witkowski, Poland’s manager for Spectrum Therapeutics.

As of January 2019, Poland became an importer of medical cannabis. This is thanks to the global producer of medical cannabis—Canopy Growth. Patients can now buy medical cannabis in pharmacies, though it is available only on prescription.

The company’s representatives estimate that there are about 300,000 people in need of medical cannabis therapy in Poland. (Source)

The facts about medical cannabis

Fact 1: Cannabis relieves chronic pain in adults and reduces nausea.

Pain management societies around the world recognize and recommend cannabis for its proven efficacy in the treatment of chronic pain. Research has shown that cannabis also reduces nausea after chemotherapy.

Fact 2: There are few side-effects from the use of cannabis.

There are scientific studies on the harmfulness of cannabis use. This study by scientists from the University of Michigan has shown that 42% of patients who use medical cannabis give up their medications. Another 38% of patients reduced their doses.

Fact 3: You can’t overdose on cannabis.

The “therapeutic index” is a quantitative measurement of the relative safety of a drug. Cannabis has a very good rating on the therapeutic index, thus indicating that it is a safe drug.

Fact 4: Medical and recreational cannabis are not the same products.

They prepare and control the production of medical cannabis throughout the production process. However, recreational cannabis is often not regulated to the same degree.

Fact 5: There are no effective substitutes for medical cannabis.

Medical cannabis doesn’t have a substitute, though some preparations are developed with synthetic cannabinoids. However, they cause different reactions and produce undesirable side effects.

The act legalizing cannabis for medical purposes in Poland came into effect on November 2017. (Source)

The myths about medical cannabis

Myth 1: Medical cannabis is addictive.

Patients undergoing medical cannabis therapy are under the care of qualified medical staff. Therefore, if they use the product as prescribed and follow doctors’ recommendations, there is no risk of addiction.

Myth 2: Cannabis in Poland is illegal.

The act legalizing cannabis for medical purposes in Poland came into force in November 2017. Poland issues legal medical cannabis products in pharmacies and only on the condition of a medical prescription.

Myth 3: Medical cannabis has no positive medical effects.

The main uses of medical cannabis are to treat chronic pain and alleviate the adverse effects caused by chemotherapy. Furthermore, it helps with radiotherapy (oncological patients), multiple sclerosis, epilepsy, and much more.

(Featured image by candelabra)

First published in Biznes Newseria, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.




Anne Kings

Anne Kings is a reporter for the financial sector, often tackling Wall Street and shareholders' interests. She also covers the intersection of media and technology, and delves into interesting topics on entertainment. Sometimes she also writes about the cannabis industry, in particular CBD and hemp. She is currently based in New York.

Recent Posts

Berlin Will Launch Pilot Project for Legal Cannabis Sales

Berlin is launching a pilot project in the Friedrichshain-Kreuzberg and Neukölln districts to study the…

1 week ago

Legalizace, Czech Cannabis Magazine, Accused of “Promoting Drug Addiction”, Wins Case

The Czech Constitutional Court overturned a previous ruling accusing Robert Veverka, former editor of Legalizace,…

2 weeks ago

U.N. High Commissioner for Human Rights Declares the War on Drugs a Failure

U.N. High Commissioner for Human Rights Volker Türk has declared the war on drugs a…

2 weeks ago

Pennsylvania Lawmakers Unveil New Plan to Legalize Cannabis

Pennsylvania lawmakers have proposed a plan to legalize recreational cannabis by 2025. Projections estimate up…

2 weeks ago

United States — First Step in DEA Hearing on Cannabis Reclassification

The DEA just held its first procedural hearing on cannabis reclassification, although the focus was…

3 weeks ago

Brazil — Supreme Court Legalizes the Cultivation, Processing, and Sale of Hemp for Medical Purposes

The Superior Court of Justice in Brazil has legalized the cultivation, processing, and sale of…

3 weeks ago